A trial to investigate benralizumab in children with eosinophilic diseases

Trial Identifier: D3255C00004
Sponsor: AstraZeneca
Start Date: April 2025
Primary Completion Date: February 2028
Study Completion Date: April 2028

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
BR São Paulo, BR, 01232-010
CA, Ontario Toronto, Ontario, CA, M5G1X8
FR Lille, FR, 59037
FR Montpellier, FR, 34295
IL Petah-Tikva, IL, 49202
IN Ahmedabad, IN, 380013
MX Guadalajara, MX, 44620
NL ROTTERDAM, NL, 3015 GD
PL Kielce, PL, 25-734
PL Warszawa, PL, 04-730
TR Altındağ, TR, 06230
TR Istanbul, TR, 34093
US, CO Aurora, CO, US, 80045
US, OH Cincinnati, OH, US, 45229
US, Ohio Highland Hills, Ohio, US, 44106-2624